文献速递流行病学与生物统计临床试验与 GCP

回归断点设计被证明是替代随机对照试验估计治疗效应的有效选择

The regression discontinuity design showed to be a valid alternative to a randomized controlled trial for estimating treatment effects.
PubMed 文献 · J Clin Epidemiol · 2016-11-16

本研究利用EVIDENT随机对照试验(RCT)数据,以基线PHQ-9=10为断点进行回归断点(RD)分析,比较RD与RCT的治疗效应估计。RD模型回归系数为-2.29(95%CI:-3.72至-0.85),RCT治疗效应为-1.57(95%CI:-2.07至-1.07),两者置信区间重叠,提示RD设计可作为RCT的有效替代。

要点

  • RD分析以基线PHQ-9=10为断点,纳入断点以上接受干预者317例和断点以下对照187例。
  • RD模型回归系数为-2.29(95%CI:-3.72至-0.85),RCT治疗效应为-1.57(95%CI:-2.07至-1.07)。
  • 两种设计的估计值不相等但置信区间重叠,提示RD设计可作为RCT的有效替代。

核心结论

  • 虽然两种设计获得的估计值不相等,但其置信区间重叠,提示RD设计可以成为RCT的有效替代。
  • 这一发现对于RCT可能不可行或不符合伦理的情形尤为重要,而这种情况在临床研究环境中经常出现。

研究设计与样本

  • 研究利用RCT(EVIDENT)的数据进行RD分析,该RCT研究互联网干预对以患者健康问卷(PHQ-9)测量的抑郁症状的效果。
  • RD分析中治疗分配由基线切点值(PHQ-9=10)决定,拟合线性回归模型,选择切点以上接受干预的参与者(n=317)和切点以下的对照参与者(n=187)。
  • 结局为基线后12周的PHQ-9总分,研究对效应估计的稳健性进行了考察,并将该估计与RCT治疗效应进行比较。

主要发现

  • 最终回归模型显示回归系数为-2.29(95%CI:-3.72至-0.85)。
  • RCT中发现的治疗效应为-1.57(95%CI:-2.07至-1.07)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare treatment effect estimates obtained from a regression discontinuity (RD) design with results from an actual randomized controlled trial (RCT). STUDY DESIGN AND SETTING: Data from an RCT (EVIDENT), which studied the effect of an Internet intervention on depressive symptoms measured with the Patient Health Questionnaire (PHQ-9), were used to perform an RD analysis, in which treatment allocation was determined by a cutoff value at baseline (PHQ-9 = 10). A linear regression model was fitted to the data, selecting participants above the cutoff who had received the intervention (n = 317) and control participants below the cutoff (n = 187). Outcome was PHQ-9 sum score 12 weeks after baseline. Robustness of the effect estimate was studied; the estimate was compared with the RCT treatment effect. RESULTS: The final regression model showed a regression coefficient of -2.29 [95% confidence interval (CI): -3.72 to -.85] compared with a treatment effect found in the RCT of -1.57 (95% CI: -2.07 to -1.07). CONCLUSION: Although the estimates obtained from two designs are not equal, their confidence intervals overlap, suggesting that an RD design can be a valid alternative for RCTs. This finding is particularly important for situations where an RCT may not be feasible or ethical as is often the case in clinical research settings.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Maas IL, Nolte S, Walter OB, et al. The regression discontinuity design showed to be a valid alternative to a randomized controlled trial for estimating treatment effects. J Clin Epidemiol. 2016. PMID: 27865902. doi:10.1016/j.jclinepi.2016.11.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。